Treatment of small cell lung carcinoma in the elderly

Cancer

Volumn 77, Issue 10, 1996, Pages 2032-2038

  Dajczman, Esther ^a   Fu, Li Yi ^a   Small, David ^a   Wolkove, Norman ^a   Kreisman, Harvey ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

elderly; investigation; management; small cell lung cancer; treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; WEIGHT LOSS;

EID: 15844385425     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960515)77:10<2032::AID-CNCR10>3.0.CO;2-W     Document Type: Article

References (31)

1. Rimer B, Jones W, Wilson C, Bennett D, Engstrom P. Planning a cancer control program for older citizens. Gerontologist 1983;23:384-9.
2. McKenna RJ. Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow-up. Cancer 1994;74:2107-17.
3. Cohen HJ. Biology of ageing as related to cancer. Cancer 1994;74:2092-100.
4. Poplin E, Thompson B, Whitacre M, Aisner J. Small cell carcinoma of the lung: influence of age on treatment outcome. Cancer Treat Rep 1987;71:291-6.
5. Carney DN, Grogan L, Smit EF, Harford P, Berendsen HH, Postmus PE. Single-agent oral etoposide for elderly small cell lung cancer patients. Semin Oncol 1990;17:49-53.
6. Johnson DH. Treatment of the elderly patient with small cell lung cancer. Chest 1993;103:72S-4S.
7. Benson AB, Prokop Pregler J, Bean JA, Rademaker AW, Eshler B, Andersen K. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois cancer center study. J Clin Oncol 1991;9:2067-75.
8. Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA. Representation of older patients in cancer treatment trials. Cancer 1994;74:2208-14.
9. Perry MC, Eaton WL, Propert KJ, Ware JH, Zimmer B, Chahinian AP, et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 1987;316:912-8.
10. Stahel RA, Ginsberg R, Havemann K, Hirsch FR, Ihde DC, Jassem J, et al. Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 1989;5:119-26.
11. Klasa RJ, Murray N, Coldman AJ. Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung. J Clin Oncol 1991;9:499-508.
12. Evans WK, Feld R, Murray N, Willian A, Coy P, Osoba D, et al. Superiority of alternating non-cross-resistant chemotherapy in extensive stage small-cell lung cancer. A Multicentered, randomized clinical trial by the national cancer institute of Canada. Ann Int Med 1987;107:451-8.
13. Feld R, Evans WK, Coy P, Hudson I, MacDonald AS, Osoba D, et al. Canadian multi-center randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. J Clin Oncol 1987; 5:1401-9.
14. Green MR. Phase III chemotherapy trials in small cell lung cancer. Lung Cancer 1989;5:178-85.
15. Ettinger DS, Finkelstein DM, Abeloff MD, Ruckdeschel JC, Aisner SC, Eggleston JC. A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group. J Clin Oncol 1990;8:230-40.
16. Quoix E, Wolkove N, Hanley J, Kreisman H. Problems in radiographic estimation of response to chemotherapy and radiotherapy in small cell lung cancer. Cancer 1988;62:489-93.
17. Breslow NE, Day NE. Statistical methods in cancer research. Vol II. The design and analysis of cohort studies. Toronto: Oxford University Press, 1987.
18. SAS Institute Inc. SAS/STAT User's Guide. 6.03 ed. Cary: SAS Institute Inc., 1988.
19. Cole BF, Gelber RD, Goldhirsch A. Cox regression models for quality adjusted survival analysis. Stat Med 1993;12:975-87.
20. Kelly P, O'Brien AAJ, Daly P, Clancy L. Small-cell lung cancer in elderly patients: the case for chemotherapy. Age Ageing 1991;20:19-22.
21. Walsh SJ, Begg CB, Carbone PP. Cancer chemotherapy in the elderly. Semin Oncol 1989;16:66-75.
22. Samet J, Hunt WC, Key C, Humble CG, Goodwin JS. Choice of cancer therapy varies with age of the patient. JAMA 1986;255:3383-90.
23. Cohen HJ, Bartolucci A. Age and the treatment of multiple myeloma. Am J Med 1995;79:316-24.
24. Tranum B, Hoogstraten B, Kennedy A, Vaughn CB, Samal B, Thigpen T, et al. Adriamycin in combination for the treatment of breast cancer. Cancer 1978;41:2078-83.
25. Foon KA, Zighelboim J, Yale C, Gale RP. Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia. Blood 1981;59:467-70.
26. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med 1989;321:303-9.
27. Smit EF, Carney DN, Harford P, Sleijfer DT, Postmus PE. A phase II study of oral etoposide in elderly patients with small cell lung cancer. Thorax 1989;44:631-3.
28. Shepard FA, Amdemichael E, Evans WK, Chalvardjian P, Hogg-Johnson S, Coates R, et al. Treatment of small-cell lung cancer in elderly. J Am Geriatr Soc 1994;42:62-70.
29. Goss GD, Logan D, Maroun J, Stewart D, Yau J, Evans WK. Chemotherapy in elderly patients with small-cell lung cancer (SCLC) (abstr 969) Proc Am Soc Clin Oncol 1992;11:290.
30. Findlay MPN, Griffin AM, Raghavan D, McDonald KE, Coates AS, Duval PJ, et al. Retrospective review of chemotherapy for small cell lung cancer in the elderly: does the end justify the means? Eur J Cancer 1991;27:1597-601.
31. Mor V, Masterson-Allens S, Goldberg RJ, Cummings FJ, Glicksman AS, Fretwell MD. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc 1985;33:585-98.